Related Experiment Video
Updated: Jun 27, 2025

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
Identification and In Vivo Validation of Unique Anti-Oncogenic Mechanisms Involving Protein Kinase Signaling and
Son Tran1, Patrick Sipila1, Satbir Thakur1
1Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Abstract:
PV-10 is a 10% formulation of rose bengal sodium that has potent immunotherapeutic and anti-cancer activity against various tumors, including metastatic melanoma and refractory neuroblastoma. Currently, PV-10 is undergoing clinical testing for refractory metastatic neuroendocrine cancer and melanomas. However, preclinical investigation of PV-10 activity and its mechanisms against phenotypically and molecularly diverse adult solid tumors had not been conducted. In a panel of human cell lines derived from breast, colorectal, head and neck, and testicular cancers, we demonstrated that PV-10 induces cytotoxicity by apoptotic and autophagic pathways involving caspase-mediated PARP cleavage, downregulation of SQSTM1/p62, and upregulation of beclin-1. Treatment with PV-10 also consistently reduced phosphorylation of WNK1, which has been implicated in cancer cell migration and autophagy inhibition. By wound healing assay, PV-10 treatment inhibited the migration of cancer cells. Finally, significant inhibition of tumor growth was also noted in tumor-bearing mice treated with PV-10 by intralesional or systemic administration. In addition to known PV-10-mediated tumor-specific cytotoxic effects, we identified the mechanisms of PV-10 and provide new insights into its effect on autophagy and metastasis. Our data provide essential mechanism-based evidence and biomarkers of activity to formulate clinical studies of PV-10 in the future.
Insights
PV-10, a rose bengal sodium formulation, shows potent anti-cancer effects by inducing apoptosis and autophagy. This study elucidates its mechanisms against diverse solid tumors, paving the way for future clinical applications.
Area of Science:
- Oncology
- Cancer Therapeutics
- Molecular Biology
Background:
- PV-10 (rose bengal sodium) exhibits immunotherapeutic and anti-cancer activity.
- Clinical trials are ongoing for PV-10 in metastatic melanomas and neuroendocrine cancers.
- Preclinical data on PV-10's mechanisms against diverse adult solid tumors were lacking.
Purpose of the Study:
- To investigate PV-10's cytotoxic mechanisms in various adult solid tumor cell lines.
- To explore PV-10's effects on apoptotic and autophagic pathways.
- To assess PV-10's impact on cancer cell migration and in vivo tumor growth.
Main Methods:
- Cytotoxicity assays on human breast, colorectal, head and neck, and testicular cancer cell lines.
- Analysis of apoptotic and autophagic markers (caspase-mediated PARP cleavage, SQSTM1/p62, beclin-1).
- Wound healing assays for cell migration and in vivo studies in tumor-bearing mice.
Main Results:
- PV-10 induced cytotoxicity via apoptosis and autophagy, involving caspase-mediated PARP cleavage, SQSTM1/p62 downregulation, and beclin-1 upregulation.
- PV-10 reduced WNK1 phosphorylation, inhibiting cancer cell migration.
- Significant tumor growth inhibition was observed in mice treated with PV-10.
Conclusions:
- PV-10 exhibits anti-cancer activity through apoptosis and autophagy induction.
- PV-10 impacts cancer cell migration and in vivo tumor progression.
- Identified mechanisms and biomarkers support future clinical studies of PV-10.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
The Intrinsic Apoptotic Pathway